Boston Scientific names Joseph Fitzgerald as COO, effective Jan. 1, 2027
Bitget2026/10/07 10:01Boston Scientific named Joseph M. Fitzgerald executive vice president and chief operating officer, effective Jan. 1, 2027. Fitzgerald will oversee global operations, business units, and regions; he previously served as executive vice president and group president, Cardiovascular. Reporting structure will shift to three segments from Jan. 1: Interventional Therapies, Rhythm Solutions, MedSurg. Lance Bates will lead Interventional Therapies; Nick Spadea-Anello will lead Rhythm Solutions; Stephen Morse will lead MedSurg and Asia Pacific. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610070600PR_NEWS_USPR_____NE65521) on October 07, 2026, and is solely responsible for the information contained therein.
- Boston Scientific named Joseph M. Fitzgerald executive vice president and chief operating officer, effective Jan. 1, 2027.
- Fitzgerald will oversee global operations, business units, and regions; he previously served as executive vice president and group president, Cardiovascular.
- Reporting structure will shift to three segments from Jan. 1: Interventional Therapies, Rhythm Solutions, MedSurg.
- Lance Bates will lead Interventional Therapies; Nick Spadea-Anello will lead Rhythm Solutions; Stephen Morse will lead MedSurg and Asia Pacific.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The battle for customer loyalty heats up ahead of the holiday season! Walmart (WMT.US) launches a $120 membership package, going head-to-head with Amazon Prime and Costco.
Walmart launched a joint membership package for Walmart+ and Sam’s Club Plus this week, directly competing with Amazon Prime and Costco.
Data: ETH falls below 2,300 USD
Survival period doubled! AstraZeneca's new stomach cancer drug Sone-ve aims for $5 billion in annual sales, ADC takes another step towards replacing chemotherapy
AstraZeneca's gastric cancer ADC doubles patient survival, extending life by five more months, aiming for annual sales of $5 billion; the company is racing with Takeda and Astellas to target Claudin 18.2.
16 trillion Korean won "big dividend"! SK hynix (SKHY.US) plans to distribute 80% of Kioxia stake earnings generously to shareholders
According to reports, SK Hynix plans to return about 80% of the proceeds from reducing its stake in Japan's Kioxia Holdings to shareholders by distributing a special dividend of approximately 16 trillion won (about $12 billion).
Crypto prices
More
